Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0482
+0.0011 (2.29%)
Jul 1, 2025, 3:50 PM EDT

Nu-Med Plus Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
0.060.060.120.180.831.98
Upgrade
Operating Expenses
0.060.060.120.180.841.99
Upgrade
Operating Income
-0.06-0.06-0.12-0.18-0.84-1.99
Upgrade
Interest Expense
-0.01-0.01-0.01-0--0.01
Upgrade
EBT Excluding Unusual Items
-0.07-0.07-0.13-0.18-0.84-2.01
Upgrade
Gain (Loss) on Sale of Assets
---0--
Upgrade
Other Unusual Items
---0.050.01-
Upgrade
Pretax Income
-0.07-0.07-0.13-0.13-0.83-2.01
Upgrade
Net Income
-0.07-0.07-0.13-0.13-0.83-2.01
Upgrade
Net Income to Common
-0.07-0.07-0.13-0.13-0.83-2.01
Upgrade
Shares Outstanding (Basic)
848482807355
Upgrade
Shares Outstanding (Diluted)
848482807355
Upgrade
Shares Change (YoY)
1.61%2.30%2.15%8.96%34.60%19.69%
Upgrade
EPS (Basic)
-0.00-0.00-0.00-0.00-0.01-0.04
Upgrade
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.01-0.04
Upgrade
Free Cash Flow
-0-0-0.07-0.04-0.21-0.41
Upgrade
Free Cash Flow Per Share
---0.00--0.00-0.01
Upgrade
EBITDA
---0.12-0.18-0.83-1.98
Upgrade
D&A For EBITDA
--000.010.01
Upgrade
EBIT
-0.06-0.06-0.12-0.18-0.84-1.99
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.